CEA determination in the follow-up of colorectal cancers
Lauterbach, M.; Dehne, A.; Hesse, V.; Höfig, G.
Zentralblatt für Chirurgie 112(15): 968-974
1987
ISSN/ISBN: 0044-409X PMID: 3673304 Document Number: 299914
CEA follow-up checks of 135 patients with colorectal carcinoma are described in a retrospective analysis. Unambiguous correlations were found to exist between clinical tumour staging and CEA findings in the context of both primary findings and recurrences and metastasation. Typical courses are described of 107 patients who received curative treatment. An assessment is made of the value of CEA determination in postoperative follow-up.
Document emailed within 1 workday
Related Documents
Bettstetter, M.; Rümmele, P.; Hofstädter, F.; Dietmaier, W. 2006: A new quantitative DNA-methylation analysis of MSi colorectal cancers helps to separate sporadic colorectal cancers from HNPCC-candidates Verhandlungen der Deutschen Gesellschaft für Pathologie 90: 236-243Sakakura, C.; Hagiwara, A.; Yamazaki, J.; Takagi, T.; Hosokawa, K.; Shimomura, K.; Kin, S.; Nakase, Y.; Fukuda, K.-I.; Yamagishi, H. 2004: Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers Hepato-Gastroenterology 51(59): 1350-1353
Bosslet, K.; Schwarz, A.; Steinstraesser, A.; Kuhlmann, L.; Seidel, L.; Schulz, G. 1988: Immunoscintigraphy of colorectal cancers and specific immunotherapy of pancreatic cancers using monoclonal antibodies Wiener Medizinische Wochenschrift 138(11-12): 255-257
Lanza, G.; Gafà, R.; Decarli, N. 2001: Pathological factors involved in lymph node status determination in colorectal carcinoma: analysis of 166 cases with long-term follow-up Pathologica 93(6): 631-639
Sakurai, Y.; Kodaira, S.; Teramoto, T.; Sugano, K.; Abe, O.; Ohtake, H.; Iri, H. 1989: Clinical evaluation of serum level of NCC-ST-439 as a new tumor marker for colorectal diseases--fluctuation of serum NCC-ST-439 in patients with colorectal cancers before and after surgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(9): 3205-3212
Lièvre, A.; Mitry, E. 2003: Chemotherapy for colorectal cancers Journal de Chirurgie 140(1): 52-55
Adenis, L.; Duval, G.; Demaille, M.C. 1979: Epidemiology of colorectal cancers Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 24(8): 649-652
Schildberg, F.W.; Lange, V.; Thies, E.; Meyer, G. 1985: Therapy of recurrent colorectal cancers Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 56(8): 509-514
Notarnicola, M.; Caruso, M.Gabriella.; Tutino, V.; De Nunzio, V.; Gigante, I.; De Leonardis, G.; Veronese, N.; Rotolo, O.; Reddavide, R.; Stasi, E.; Miraglia, C.; Nouvenne, A.; Meschi, T.; De' Angelis, G.Luigi.; Di Mario, F.; Leandro, G. 2018: Nutrition and lipidomic profile in colorectal cancers Acta Bio-Medica: Atenei Parmensis 89(9-S): 87-96
Thiagalingam, S.; Lisitsyn, N.A.; Hamaguchi, M.; Wigler, M.H.; Willson, J.K.; Markowitz, S.D.; Leach, F.S.; Kinzler, K.W.; Vogelstein, B. 1996: Evaluation of the FHIT gene in colorectal cancers Cancer Research 56(13): 2936-2939
van den Broek, M.H.; Jhanwar, S.C.; Fodde, R.; Chaganti, R.S.; Meera Khan, P.M. 1993: P53 mutations in colorectal cancers in the patients of Metropolitan New York Anticancer Research 13(5C): 1769-1772
Zhan, J.; Liu, J-ping.; Zhu, Z-hua.; Yao, H-rui.; Chen, C-yan. 2004: Relationship between COX-2 expression and clinicopathological features of colorectal cancers Chinese Medical Journal 117(8): 1151-1154
Klingler, K.; Zhang, X.; Menghini, T.; Metzger, U.; Largiadèr, F. 1989: Effect of blood transfusions on the survival of patients with colorectal cancers Helvetica Chirurgica Acta 55(5): 685-688
Ooyama, S.; Yamaguchi, A.; Yonemura, Y.; Takegawa, S.; Kosaka, T.; Miwa, K.; Miyazaki, I. 1990: Metastasis and its relation to cell kinetics in human colorectal cancers Nihon Geka Gakkai Zasshi 91(6): 677-682
Koda, K.; Glassy, M.C.; McKnight, M.E.; Yasutomi, J.; Saito, N.; Dan, M.; Nakajima, N. 2001: Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1 Anticancer Research 21(1b): 621-627
Kasakura, Y.; Fujii, M.; Mochizuki, F.; Kobayashi, M.; Yamagata, M. 2001: Clinicopathological analyses of advanced colorectal cancers of different sizes--especially those of 20 mm or less in diameter Hepato-Gastroenterology 48(39): 696-701
Chereches, G.; Barbos, O.; Buiga, R.; Balacescu, O.; Iancu, D.; Todor, N.; Balacescu, L.; Miron, N.; Bejinariu, N.; Ciuleanu, T.-E. 2017: Biomarkers for the early detection of relapses in metastatic colorectal cancers Journal of Buon: Official Journal of the Balkan Union of Oncology 22(3): 658-666
Rohner, A. 1982: Indications for the surgical treatment of recurring colorectal cancers and their metastases Helvetica Chirurgica Acta 48(6): 873-878
Geryk, E.; Horváth, T.; Konecný, M. 2011: The expected worldwide burden of oesophagus, stomach and colorectal cancers Vnitrni Lekarstvi 57(12): 1006-1011
Misset, J.L. 1997: Chemotherapy of advanced colorectal cancers after failure of a treatment with fluoropyrimidine La Revue du Praticien 47(12 Spec No): S29-S35